Data / Form D filings / Starget Pharma Inc.
Starget Pharma Inc.: Form D filing
Starget Pharma Inc., a biotechnology company in Shreveport, LA, filed a Form D with the SEC in 2026. The latest, on February 3, 2026, reports $16.4 million sold of a $22.2 million offering to 29 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2031 KINGS HIGHWAY, Shreveport, LA, 71103
- Phone
- (318) 746-8430
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2108969
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | New notice | $22,158,515 | $16,373,737 | $5,784,778 | 29 | Jan 20, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sigal Kalmanson Cusnir | Executive Officer | |
| Ronen Kalmanson | Director |
Other biotechnology companies in Louisiana that filed recently
- 28bio, Inc. $8.5 million · Oct 29, 2026
- Therapeutic Neuromodulation Systems LLC $1.7 million · Sep 21, 2026
- QUICKTAKE HEALTH CO $2.1 million · Aug 6, 2026
Every Form D from the week of Feb 2, 2026 · All recent filings in Louisiana · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Starget Pharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.